Bristol-Myers Squibb Company (BMY) is in Healthcare, Drug Manufacturers - General, based in United States, listed on NYSE. Market cap 121.70B USD. 52-week range 42.52 to 68.64 USD. Trailing P/E 13.1. Data as of 2026-10-09.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic ...